WELLINGTON MANAGEMENT GROUP LLP
Position in BMRN — Biomarin Pharmaceutical Inc
CIK 902219
Boston, MA
Position in BMRN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$40,476,384
-$6,181,810 QoQ
Shares Held
716,523
-8.7% QoQ
Ownership
0.370%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2023
7 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in BMRN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026WELLINGTON MANAGEMENT GROUP LLP holds $14,994,233,945 across 206 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,247,658 | $1,613,209,155 | |
| 2 | ARGX |
Argenx SE
|
930,548 | $863,334,513 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,270,087 | $791,950,042 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,843,415 | $719,794,757 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,110,407 | $635,295,816 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
7,651,415 | $606,680,693 | |
| 7 | CYTK |
Cytokinetics Inc
|
6,931,770 | $590,517,483 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
825,714 | $443,367,129 |
All Filings in BMRN
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $40,476,384 | 716,523 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $46,658,194 | 785,095 | Shares | Defined | 2026-02-17 | |
| 2024-12-31 | $490,411 | 7,461 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $496,176 | 7,059 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $569,476 | 6,917 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $551,988 | 6,320 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $584,883 | 6,066 | Shares | Defined | 2024-02-12 | |
| No filing history on record for this holder in this stock. | ||||||